Thomas Lönngren
Chairman chez EGETIS THERAPEUTICS AB
Fortune : 917 841 $ au 31/03/2024
Profil
Dr. Thomas Lönngren is a Chairman at Egetis Therapeutics AB and an Independent Director at Compass Pathways Plc.
He is on the Board of Directors at Compass Pathways Plc, Pharma Executive Consulting Ltd.
and NDA Group AB.
Dr. Lönngren was previously employed as a Non-Executive Director by Analytica Ltd., a Non-Executive Director by CBio Ltd., a Member by Royal Pharmaceutical Society of Great Britain, an Executive Director by The European Medicines Agency, a Deputy General Director by The Medical Products Agency, and a Deputy Director-General by Läkemedelsverket.
He also served on the board at Global Kinetics Pty Ltd.
He received his undergraduate degree from the University of Uppsala and a graduate degree from the University of Uppsala.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
COMPASS PATHWAYS PLC
0,25% | 03/04/2023 | 89 049 ( 0,25% ) | 740 888 $ | 31/03/2024 |
EGETIS THERAPEUTICS AB
0,10% | 31/12/2022 | 283 248 ( 0,10% ) | 176 954 $ | 31/03/2024 |
Postes actifs de Thomas Lönngren
Sociétés | Poste | Début |
---|---|---|
COMPASS PATHWAYS PLC | Director/Board Member | 01/09/2019 |
EGETIS THERAPEUTICS AB | Chairman | 01/04/2021 |
Pharma Executive Consulting Ltd. | Founder | 01/01/2011 |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Director/Board Member | 01/01/2011 |
Anciens postes connus de Thomas Lönngren
Sociétés | Poste | Fin |
---|---|---|
ANALYTICA | Director/Board Member | 18/08/2020 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Director/Board Member | 28/12/2011 |
The European Medicines Agency | Director/Board Member | 31/12/2010 |
The Medical Products Agency
The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Corporate Officer/Principal | 01/12/2000 |
Global Kinetics Pty Ltd.
Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Formation de Thomas Lönngren
University of Uppsala | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
EGETIS THERAPEUTICS AB | Health Technology |
COMPASS PATHWAYS PLC | Health Technology |
Entreprise privées | 9 |
---|---|
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
Analytica Ltd.
Analytica Ltd. Medical SpecialtiesHealth Technology Analytica Ltd. engages in the design development, and supply of class 1 and class 2 medical devices. It operates through the following segment: Medical Devices and Corporate. The Medical Devices segment is consist of AutoStart Burette, PeriCoach, and ELF 2. The Corporate segment includes all other operations including the administration, and associated listed public company expenditure. The company is headquartered in Brisbane, Australia. | Health Technology |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
The European Medicines Agency | Government |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Commercial Services |
Läkemedelsverket | |
Global Kinetics Pty Ltd.
Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Pharma Executive Consulting Ltd. | |
The Medical Products Agency
The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Health Technology |